X Bioscience PCL (BKK:XBIO) Quick Ratio: 0.97 (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is X Bioscience PCL Quick Ratio?

X Bioscience PCL BKK:XBIO Quick Ratio is 0.97 as of Mar. 2026, which is 4% below its 10-year median of 1.01. The stock has 6 warning signs investors should review. Among 363 Restaurants companies, X Bioscience PCL ranks better than 57.02% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. X Bioscience PCL's quick ratio for the quarter that ended in Mar. 2026 was 0.97.

X Bioscience PCL has a quick ratio of 0.97. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for X Bioscience PCL's Quick Ratio or its related term are showing as below:

BKK:XBIO' s Quick Ratio Range Over the Past 10 Years
Min: 0.06   Med: 1.01   Max: 29.62
Current: 0.97

During the past 13 years, X Bioscience PCL's highest Quick Ratio was 29.62. The lowest was 0.06. And the median was 1.01.

BKK:XBIO's Quick Ratio is ranked better than
57.02% of 363 companies
in the Restaurants industry
Industry Median: 0.86 vs BKK:XBIO: 0.97

X Bioscience PCL  (BKK:XBIO) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


X Bioscience PCL Quick Ratio Related Terms


X Bioscience PCL Quick Ratio Historical Data

* Premium members only.

The historical data trend for X Bioscience PCL's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

X Bioscience PCL Quick Ratio Chart

X Bioscience PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.09 0.15 0.22 0.92

X Bioscience PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 1.09 1.05 0.92 0.97

BKK:XBIO vs SYY, USFD, PFGC: Quick Ratio Comparison

For the Restaurants subindustry, X Bioscience PCL's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


X Bioscience PCL Quick Ratio vs Restaurants Industry

For the Restaurants industry and Consumer Cyclical sector, X Bioscience PCL's Quick Ratio distribution charts can be found below:

* The bar in red indicates where X Bioscience PCL's Quick Ratio falls into.



X Bioscience PCL Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

X Bioscience PCL's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(301.719-2.22)/325.807
=0.92

X Bioscience PCL's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(310.037-1.616)/318.234
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.97 mean?
X Bioscience PCL (BKK:XBIO) has a Quick Ratio of 0.97 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on X Bioscience PCL and its competitors. This is near median its historical median of 1.01. Over the past decade, X Bioscience PCL's Quick Ratio has ranged from 0.06 to 29.62. According to the industry distribution chart, X Bioscience PCL ranks #156 out of 363 companies in the Restaurants industry, placing it in the top 43%.
Is X Bioscience PCL's Quick Ratio too high?
X Bioscience PCL's current Quick Ratio of 0.97 is near median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 29.62. The Restaurants industry median Quick Ratio is 0.86. X Bioscience PCL's value of 0.97 is 12.8% above this industry median. Based on the distribution chart, X Bioscience PCL ranks #156 out of 363 companies in the Restaurants industry, which is above the industry midpoint.
How does X Bioscience PCL's Quick Ratio compare to SYY and USFD?
According to the Restaurants industry distribution chart, X Bioscience PCL ranks #156 out of 363 companies for Quick Ratio. This puts X Bioscience PCL in the upper half of its industry. The industry median Quick Ratio is 0.86. X Bioscience PCL's value of 0.97 is 12.8% above this benchmark. Historically, X Bioscience PCL's own Quick Ratio has ranged from 0.06 to 29.62 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 0.86, X Bioscience PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Restaurants company?
The median Quick Ratio among Restaurants companies is 0.86, based on 363 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. X Bioscience PCL's current Quick Ratio of 0.97 is 12.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on X Bioscience PCL and its competitors. For the Restaurants industry, the median Quick Ratio is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X Bioscience PCL's current Quick Ratio is 0.97, which is near median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current Quick Ratio is 0.97, which is near median its 10-year median of 1.01 and 12.8% above the Restaurants industry median of 0.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current Quick Ratio is 0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

X Bioscience PCL Business Description

Other Exchanges XBIO-W7:Thailand
Address Phaholyothin Road, No. 304, Vanit Place Aree Tower, Tower A, Units 1803-1806, 18th Floor, Samsennai, Phayathai District, Bangkok, THA, 10400
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.